Introduction
Carrotosis is a group of diseases caused by a fungus of carcinogens, which can be drained to the lungs, snout, eye and other organ systems and can endanger life in serious cases. With the increase in the number of people affected by immunization and advances in diagnostic techniques, the incidence of carcinoma has gradually increased. As the foundation of the health-care system, primary health-care institutions have important responsibilities in the early detection and treatment of carcinoma, but they are currently facing many challenges in the treatment of the disease and are in dire need of scientific and effective strategies and practices.
II. Current situation and challenges facing primary health-care institutions
(i) Limited diagnostic techniques
Basic medical institutions often lack advanced microbiological diagnostic equipment, such as PCR technology, mass spectrometry, etc., for the detection of cartilage, and rely mainly on traditional fungi culture and microscope screening methods. However, it takes a long period of time, usually from days to weeks to achieve positive results, and the positive rate is influenced by a number of factors, which can cause delays in diagnosis and miss the best treatment. In addition, there is a lack of awareness among primary health-care personnel of the visual characteristics of the disease, and the difficulty of accurately distinguishing it from other lung diseases in the diagnosis of images such as chest X-rays or CTs further increases the difficulty of early diagnosis.
(ii) Lack of expertise
Most primary health-care workers have not received systematic training in fungal pathology, and there is a lack of in-depth knowledge of the morbidity mechanisms, clinical performance, diagnostic standards and treatment programmes for ailments. In the course of treatment, it is difficult to determine accurately the severity and prognosis of the disease and there is a knowledge gap in the choice of anti-fluent drugs, dosage adjustments and monitoring of adverse effects, leading to a significant deterioration in the regulation and effectiveness of treatment.
(iii) Access to drugs and regulatory use
New anti-accuraic drugs, such as Volisconol and Persaconol, are under-equipped in primary health-care facilities, while traditional drugs, Genderacin B, have greater side effects and have concerns about their use by primary health-care staff. At the same time, there is a lack of in-depth understanding of drug pharmaceutical dynamics and drug ergonomics, and irregularities in drug dosage, treatment and co-use, affecting treatment effectiveness and potentially increasing the risk of adverse drug reactions.
Scientific treatment strategies and practices
(i) Enhanced training and updating of knowledge
Primary level medical staff are regularly organized to attend academic lectures, training courses and case discussions on the subject of fungal disease and are invited to give lectures by specialists on basic theoretical knowledge of the disease, advances in diagnostic techniques, up-to-date treatment guidelines and sharing of clinical practice. Through a combination of on-line and off-line training, people at the grass-roots level have been raised in their level of awareness of and capacity for the treatment of the disease, ensuring that they have access to basic diagnostic points and standardized treatment programmes, such as the choice of the first treatment for invasive pneumoccal disease, dosage calculations and follow-up drug-based treatment.
(ii) Optimization of diagnostic processes and technology applications
Primary health-care facilities should set up a simple and effective process for the diagnosis of the disease, taking into account their own situation. In case of suspicion of crony disease, the patient ‘ s medical history is first examined in detail, including basic diseases, immunisation status, occupational exposure and recent history of medication, and the clinical performance of the patient, such as lung symptoms, fever characteristics, etc. In highly suspected cases, the timely collection of suitable specimens (e.g. sapling, bronchial pulmonary pneumatic shampoo, tissue biopsy samples, etc.) is sent to a higher hospital for rapid testing (e.g. PCR tests), while traditional smears and culture tests are carried out at the grass-roots level to improve the accuracy and timeliness of diagnosis. In addition, tele-medicine platforms are used to upload the patient ‘ s video materials to higher-level hospitals, with the assistance of specialized video doctors, to determine whether the pulmonary pathologies are consistent with the visual characteristics of the disease, such as the chorus of the lung, the formation of empty holes, the vertebrate and the new month of air, thus providing strong support for early diagnosis.
(iii) Ensuring the availability and rational use of drugs
The health administration should coordinate the drug procurement department and the pharmaceutical company, ensure that primary health-care facilities are equipped with the necessary anti-curricular drugs, especially first-line treatment drugs such as Vulcanium, and establish a reasonable mechanism for the storage and allocation of drugs. At the same time, training in drug use for primary health-care personnel has been stepped up to improve the safety and effectiveness of drug treatment through, inter alia, the development of detailed drug use manuals and the development of guidance for clinical pharmacists on the location of anti-curricular drugs. For example, in the use of VC treatment, appropriate doses are calculated strictly on the basis of the patient ‘ s body weight, liver and kidney function, and the adverse effects of the drug, such as hepatotoxicity, visual impairment, are closely monitored, and the drug programme is adjusted in a timely manner to ensure that the patient is able to withstand the treatment and obtain the best possible treatment.
Conclusions
While primary health-care institutions face multiple challenges in the areas of diagnosis, treatment and the availability of knowledge, the implementation of scientific strategies and practices, such as the training of personnel, the optimization of diagnostic processes and the provision of medicines, can gradually increase the level of treatment for the disease, early diagnosis and treatment, the reduction of mortality and disability rates, the upgrading of the capacity of primary health-care institutions to provide comprehensive services, the provision of better quality and efficient medical services to a large number of patients, the important role played on the ground level in the prevention and treatment of the disease, and the promotion of progress and development of the overall level of health care and the health of the population.
